NTRA

NATERA INC

NTRA·632307104·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

NTRA (NATERA INC) is held by 289 institutional investors as of Q2 2026. Largest holders: JPMORGAN CHASE & CO ($3.5B), BlackRock, Inc. ($3B), VANGUARD CAPITAL MANAGEMENT LLC ($1.7B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 182 funds bought NTRA.

289
Holders
(23 Elite)
$30.6B
Total Value
63% (289)
Consensus
182 buying - 107 selling
13F: Insider & Congress: Updated regularly
NTRA

Smart Money Verdict

View all
Loading verdict
Held by 289 funds
23 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 28, 2026 · Activists Aug 14, 2026 · Congress Oct 15, 2025

ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.6.3%Aug 14, 2026
InsiderFJFesko JohnSell $2.1MAug 10, 2026
InsiderSJSheena JonathanSell $2.0MAug 10, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
12.9M(-3.9%)$3.5B0.2%+106.73%
0
Increased
10.9M(+2.2%)$3B0.0%+111.80%
33
Increased
6.2M(+3.7%)$1.7B0.0%+61.70%
33
Increased
5.8M(+2.4%)$1.6B0.1%+62.27%
33
Increased
5.5M(+113.4%)$1.5B0.1%+45.18%
51
Decreased
4M(-15.3%)$1.1B0.2%+92.10%
0
Increased
3.7M(+7.0%)$992.3M0.0%+232.06%
34
Decreased
2.8M(-0.9%)$744.6M0.0%+295.87%
0
Increased
2.7M(+9.7%)$739.9M0.2%+129.73%
42
Increased
2.6M(+2.6%)$704.8M3.2%+115.73%
60
Decreased
2.5M(-1.4%)$680M1.4%+49.99%
0
Increased
2.3M(+3.1%)$628.1M0.2%+122.28%
39
Decreased
2.2M(-30.8%)$602.2M2.8%+354.56%
0
Decreased
2M(-3.4%)$535.1M0.2%+276.17%
0
Increased
1.8M(+1.2%)$482.6M1.6%+492.04%
50
Increased
1.7M(+124.2%)$466.9M0.0%+51.18%
50
Increased
1.5M(+2.5%)$408.4M0.0%+149.23%
32
Increased
1.5M(+26.2%)$408.2M0.2%+60.33%
46
Increased
1.4M(+15.8%)$368.3M3.3%+128.65%
66
Increased
1.3M(+160.4%)$347.3M0.2%+40.70%
60

Showing 1-20 of 298

1 / 15
NTRANTRANATERA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used